Posters and Oral presentations

Posters and oral presentations:

American Association for Cancer Research (AACR) Virtual Annual Meeting, 22-24 June 2020

American Association for Cancer Research (AACR) Virtual Annual Meeting, 22-24 June 2020

Kuryk and Møller
"Next generation ONCOS oncolytic adenovirus with novel anti-cancer double-transgenes shows synergistic anti-cancer effect in a melanoma mouse model"
ASGCT, virtual conference Next-gen virus poster 12 -15 May 2020

ASGCT, virtual conference Next-gen virus poster 12 -15 May 2020

Kuryk and Møller
“Next generation ONCOS double transgene oncolytic adenovirus exhibits enhanced anti-cancer effect in pre-clinical melanoma model”
ASGCT, virtual conference Next-gen virus poster 12 -15 May 2020

ASGCT, virtual conference Next-gen virus poster 12 -15 May 2020

Kuryk and Møller
“Oncolytic Adenovirus Ad5/3-D24-GM-CSF Infects, Replicates and Lyses Ovarian Cancer Cells Through Desmoglein-2 Cell Entry Receptor”
13th International Adenovirus Meeting, September 2018 – POSTER

13th International Adenovirus Meeting, September 2018 – POSTER

Kuryket al.
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 in peritoneal mesothelioma mouse model
21st Annual Meeting ASGCT, May 2018 – POSTER

21st Annual Meeting ASGCT, May 2018 – POSTER

Kuryket al.
The combinatory treatment of the oncolytic adenovirus ONCOS-102 with anti PD-1 (KEYTRUDA®) show synergistic anti-tumor effect in humanized A2058 melanoma huNOG mouse model
ESMO 2017 Congress, September 2017 – POSTER

ESMO 2017 Congress, September 2017 – POSTER

Ponceet al.
ONCOS-102 and Pemetrexed/cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma
SITC 30th Annual Meeting, Nov 2015 – POSTER

SITC 30th Annual Meeting, Nov 2015 – POSTER

Pesonenet al.
Local immunotherapy with ONCOS-102 shapes harmful tumor associated CD68+ macrophages to become beneficial cells that correlate with increased overall survival
ASCO Annual Meeting, May 2015 – POSTER

ASCO Annual Meeting, May 2015 – POSTER

Pesonenet al.
An evaluation of local and systemic immune markers following intratumoral administration of a chimeric adenovirus Ad5/3-D24-GMCSF in refractory cancer patients with solid tumors
EORTC-NCI-AACR, Nov 2014 – POSTER

EORTC-NCI-AACR, Nov 2014 – POSTER

Pesonenet al.
Tumor-infiltrating lymphocytes (TILs) following intratumoral administration of ONCOS-102 are associated with prolonged overall survival in last line solid tumor patients
SITC 29th Annual Meeting, Nov 2014 – POSTER

SITC 29th Annual Meeting, Nov 2014 – POSTER

Majumderet al.
Gene expression analysis of tumors demonstrates an induction of Th1 type immune response following intratumoral administration of ONCOS-102 in refractory solid tumor patients
CRI Annual International Cancer Immunotherapy Symposium, Oct 2014 – POSTER

CRI Annual International Cancer Immunotherapy Symposium, Oct 2014 – POSTER

Pesonenet al.
Intratumoral ONCOS-102 Shapes the Tumor Microenvironment in Last-Line Refractory Solid Tumor Patients
CIMT Annual Meeting, May 2014 – POSTER & ORAL PRESENTATION

CIMT Annual Meeting, May 2014 – POSTER & ORAL PRESENTATION

Pesonenet al.
Characterization of tumor-infiltrating lymphocytes following intratumoral administration of ONCOS-102 for refractory solid tumor cancer patients
CIMT Annual Meeting, May 2014 – POSTER & ORAL PRESENTATION

CIMT Annual Meeting, May 2014 – POSTER & ORAL PRESENTATION

Rankiet al.
Induction of anti-tumor CD8+ T cells and prominent infiltration of lymphocytes with a Th1 polarizing signature to pleural mesothelioma tumor after intratumoral injection of ONCOS-102
CIMT Annual Meeting, May 2014 – POSTER

CIMT Annual Meeting, May 2014 – POSTER

Vassilevet al.
Repeated intratumoral administration of ONCOS-102 leads to robust cellular and transcriptional immune activation at tumor site in an ovarian cancer patient